Pfizer, Lilly 'most favored nation' deals to give US share of raised foreign prices

Summary

Pfizer and Eli Lilly have signed 'most favored nation' pricing deals with the Trump administration that would provide the U.S. government a share of revenue from price increases the companies implement in foreign markets.